🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 180 of 200 · A–Z by INN

  1. tenofovir disoproxil + emtricitabine

    CIPLA TENOFOVIR + EMTRICITABINE 300/200 Cipla Australia Pty Ltd

    TGA: approved

  2. tenofovir disoproxil + emtricitabine + efavirenz

    TENOFOVIR DISOPROXIL EMTRICITABINE EFAVIRENZ VIATRIS 300/200/600 Alphapharm Pty Ltd

    TGA: approved

  3. tenofovir disoproxil fumarate

    TENOFOVIR DISOPROXIL FUMARATE Teva Pharma GmbH

    ORAL FDA: approved

  4. teplizumab

    TEIZEILD

    EMA: approved · NMPA: clinical trials

    A10XX01

  5. teplizumab-mzwv

    TZIELD

    INJECTION FDA: approved

  6. tepotinib

    TEPMETKO Merck KGaA, Darmstadt, Germany

    EMA: approved · TGA: approved · NMPA: clinical trials

    L01EX21

  7. tepotinib hydrochloride

    TEPMETKO

    ORAL FDA: approved

  8. tepotinib hydrochloride hydrate

    TEPMETKO

    PMDA: approved

  9. teprotumumab

    TEPEZZA

    EMA: approved

    L04AG13

  10. teprotumumab-trbw

    TEPEZZA

    INJECTION FDA: approved

  11. terazosin hydrochloride

    TERAZOSIN HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  12. terbinafine

    APO-TERBINAFINE Alphapharm Pty Ltd

    TOPICAL FDA: approved · TGA: approved

  13. terbinafine hydrochloride

    TERBINAFINE HYDROCHLORIDE

    TOPICAL FDA: approved

  14. terbutaline

    BRICANYL AstraZeneca

    TGA: approved

  15. terbutaline sulfate

    TERBUTALINE SULFATE

    ORAL FDA: approved

  16. terconazole

    TERCONAZOLE

    VAGINAL FDA: approved

  17. teriflunomide

    APO-TERIFLUNOMIDE Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AK02

  18. teriparatide

    RITOSA Lacuna Pharma Pty Ltd

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    H05AA02

  19. teriparatide acetate

    PARATHAR

    INJECTION FDA: approved

  20. terlipressin

    NMPA: clinical trials

  21. terlipressin acetate

    TERLIVAZ

    INTRAVENOUS FDA: approved

  22. terlipressinum

    NMPA: clinical trials

  23. tesamorelin

    EGRIFTA

    EMA: application withdrawn · NMPA: clinical trials

  24. tesamorelin acetate

    EGRIFTA

    SUBCUTANEOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources